Ajanta Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma has submitted to BSE and NSE a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate was issued by the company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited, for the quarter ended 30th June 2025. The RTA confirms that all securities received from depository participants for dematerialization during the quarter were duly accepted or rejected and reported to the depositories. It also confirms that physical share certificates received were mutilated and cancelled after verification, and the depository's name was substituted in the register of members as the registered owner within the prescribed timelines.
This is a routine quarterly compliance filing required by SEBI and has no direct impact on the company's financials, operations, or share price. Investors can take it as a sign of normal administrative housekeeping, not as a positive or negative trigger.